A phase II study of Cabazitaxel chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Penile cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms JAVA-P
- 10 Apr 2017 Status changed from recruiting to completed.
- 02 Apr 2015 Accrual to date is 11% according to United Kingdom Clinical Research Network.
- 09 Feb 2015 Accrual to date is 5% according to United Kingdom Clinical Research Network.